Its safety profile is well-established, with the most common side effects being mild gastrointestinal issues such as nausea, vomiting, and diarrhea
(BMI Criteria) Health Canada approved Wegovy for chronic weight management in adults with a body-mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea always alongside a reduced-calorie diet and increased activity
It is worth noting that headache prevalence in the general population is substantial, with tension-type headaches and migraines affecting millions of Americans
We explain what side effects may appear and how to address them quickly
To address the problem, Okava and Vivani Medical are partnering to develop OKV-119, a long-acting implant designed to support weight loss in dogs and cats
The ballooning weight loss demand for these drugs has led to diabetic patients having difficulty in sourcing them, particularly in the US